<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
	<channel>
		<title>obecure - Press Releases</title>
		<link>http://obecure.com/xml/static_news.php?sid=322&amp;lang=en</link>
		<description>obecure events display</description>
		<language>en</language>
		<adminEmail>yaffa@bio-light.co.il</adminEmail>
		<creationDate>2010-09-04T23:07:56+03:00</creationDate>
		<creator>Virtual Point</creator>
		<RSSAdminEmail>info@websplanet.com</RSSAdminEmail>
	<item>
		<title>Obecure Announces Commencement of a Follow-Up Trial to Evaluate the Safety and Efficacy of Histalean® in Mitigating Weight Gain Caused by Treatment with the Antipsychotic drug, Zyprexa®</title>
		<pubDate>2010-07-13T01:01:01+03:00</pubDate>
		<description></description>
		<link>http://obecure.com/index.php?sid=322&amp;lang=en&amp;act=static%20news&amp;id=156390</link>
		<image></image>
	</item>
	<item>
		<title>Obecure Is Granted Methods and Composition Patents Covering Adjunctive Use of Betahistine to Mitigate Weight Gain Associated With Olanzapine</title>
		<pubDate>2010-02-22T01:01:01+02:00</pubDate>
		<description></description>
		<link>http://obecure.com/index.php?sid=322&amp;lang=en&amp;act=static%20news&amp;id=137402</link>
		<image></image>
	</item>
	</channel>
</rss>